ALBIREO PHARMA INC - COMMON STOCK (ALBO)

Historical Holders from Q3 2016 to Q3 2025

Type / Class
Equity / COMMON STOCK
Symbol
ALBO
Price per share
$744.00
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares as of 30 Sep 2025
1
Total reported value
$744
Share change
0
Number of holders
1
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of ALBIREO PHARMA INC - COMMON STOCK (ALBO) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (% of par) Investors
2025 Q3 1 $744 74,400% 1
2025 Q2 1 $744 74,400% 1
2025 Q1 1 $744 74,400% 1
2024 Q4 1 $744 74,400% 1
2024 Q3 1 $744 74,400% 1
2024 Q2 1 $744 74,400% 1
2024 Q1 1 $744 74,400% 1
2023 Q4 1 $744 74,400% 1
2023 Q3 1 $744 74,400% 1
2023 Q2 1 $756 -$2,035,000 75,600% 1
2023 Q1 46,081 $2,035,799 -$415,687,587 4,444.44% 3
2022 Q4 18,610,820 $401,651,185 -$20,554,255 2,161% 94
2022 Q3 19,143,878 $370,387,747 +$26,779,264 1,936% 103
2022 Q2 17,754,471 $352,558,617 +$18,502,559 1,985.95% 96
2022 Q1 16,604,290 $495,386,841 +$20,712,174 2,983% 106
2021 Q4 15,564,742 $362,483,495 -$3,382,606 2,328.91% 94
2021 Q3 15,287,193 $476,975,740 -$8,796,684 3,120% 92
2021 Q2 15,522,619 $546,133,262 -$35,490,751 3,518.02% 97
2021 Q1 16,735,026 $589,776,641 +$1,566,884 3,525% 99
2020 Q4 16,671,414 $625,315,261 +$41,708,812 3,751% 105
2020 Q3 16,254,769 $542,366,618 +$181,989,940 3,337% 106
2020 Q2 10,264,658 $271,875,564 -$3,904,527 2,649.04% 77
2020 Q1 10,438,997 $170,709,481 +$17,420,007 1,637% 65
2019 Q4 9,002,263 $228,838,800 +$412,246 2,542% 69
2019 Q3 9,052,163 $181,039,060 -$8,676,710 2,000% 68
2019 Q2 9,259,119 $298,421,543 +$26,561,257 3,224% 72
2019 Q1 8,470,619 $272,758,817 +$14,005,444 3,220.99% 69
2018 Q4 8,037,472 $194,513,403 +$4,845,885 2,452.87% 67
2018 Q3 7,731,860 $254,843,089 +$4,317,688 3,296% 63
2018 Q2 7,595,688 $269,653,825 +$38,393,492 3,550.05% 68
2018 Q1 6,541,586 $213,070,205 +$106,354,299 3,257% 49
2017 Q4 3,193,501 $81,755,000 +$16,436,574 2,560.02% 26
2017 Q3 2,597,832 $54,423,000 +$3,544,043 2,094.83% 20
2017 Q2 2,429,234 $50,043,000 +$28,621,760 2,060.03% 20
2017 Q1 1,033,960 $24,813,000 +$1,394,598 2,399.98% 14
2016 Q4 978,234 $17,342,000 +$15,410,815 1,773.01% 14
2016 Q3 108,667 $47,000 +$47,000 43.25% 1